<SEC-DOCUMENT>0001171843-23-003988.txt : 20230620
<SEC-HEADER>0001171843-23-003988.hdr.sgml : 20230620
<ACCEPTANCE-DATETIME>20230620081512
ACCESSION NUMBER:		0001171843-23-003988
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20230619
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230620
DATE AS OF CHANGE:		20230620

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HARVARD BIOSCIENCE INC
		CENTRAL INDEX KEY:			0001123494
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				043306140
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33957
		FILM NUMBER:		231023461

	BUSINESS ADDRESS:	
		STREET 1:		84 OCTOBER HILL RD
		CITY:			HOLLISTON
		STATE:			MA
		ZIP:			01746
		BUSINESS PHONE:		5088938999

	MAIL ADDRESS:	
		STREET 1:		84 OCTOBER HILL ROAD
		CITY:			HOLLISTON
		STATE:			MA
		ZIP:			01746
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>f8k_062023.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:HBIO="http://harvardbioscience.com/20230619">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_030_HBIO_harvardbioscience.com_20230619 -->
<!-- Field: Set; Name: xdx; ID: xdx_04F_20230619_20230619 -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DEntityCentralIndexKey_0001123494 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-06-19to2023-06-19" name="dei:EntityCentralIndexKey">0001123494</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-06-19to2023-06-19" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="hbio-20230619.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-06-19to2023-06-19">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001123494</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-06-19</xbrli:startDate>
        <xbrli:endDate>2023-06-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">_____________________</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_901_edei--DocumentType_c20230619__20230619_zLl52RgfDedf"><ix:nonNumeric contextRef="From2023-06-19to2023-06-19" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">_____________________</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4pt 0pt 0; text-align: center">Date of Report (Date of earliest event
Reported): <span id="xdx_902_edei--DocumentPeriodEndDate_c20230619__20230619_zhkKFYnfSKSc"><ix:nonNumeric contextRef="From2023-06-19to2023-06-19" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">June 19, 2023</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_900_edei--EntityRegistrantName_c20230619__20230619_zVFun7LgoQCc"><ix:nonNumeric contextRef="From2023-06-19to2023-06-19" name="dei:EntityRegistrantName">HARVARD BIOSCIENCE, INC.</ix:nonNumeric></span></b></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact Name of Registrant as Specified in Charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: center; width: 33%"><b><span id="xdx_906_edei--EntityIncorporationStateCountryCode_c20230619__20230619_zQ1fDBTbKXjh"><ix:nonNumeric contextRef="From2023-06-19to2023-06-19" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></td>
  <td style="text-align: center; width: 34%"><b><span id="xdx_90B_edei--EntityFileNumber_c20230619__20230619_zLQJvDiSXBY4"><ix:nonNumeric contextRef="From2023-06-19to2023-06-19" name="dei:EntityFileNumber">001-33957</ix:nonNumeric></span></b></td>
  <td style="text-align: center; width: 33%"><b><span id="xdx_90E_edei--EntityTaxIdentificationNumber_c20230619__20230619_zjmUUhd0fNwk"><ix:nonNumeric contextRef="From2023-06-19to2023-06-19" name="dei:EntityTaxIdentificationNumber">04-3306140</ix:nonNumeric></span></b></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: center">(State or Other Jurisdiction of Incorporation)</td>
  <td style="text-align: center">(Commission File Number)</td>
  <td style="text-align: center">(I.R.S. Employer Identification No.)</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_906_edei--EntityAddressAddressLine1_c20230619__20230619_zsxF07j7S303"><ix:nonNumeric contextRef="From2023-06-19to2023-06-19" name="dei:EntityAddressAddressLine1">84 October Hill Road</ix:nonNumeric></span>, <span id="xdx_901_edei--EntityAddressCityOrTown_c20230619__20230619_zaB45eZUn2o1"><ix:nonNumeric contextRef="From2023-06-19to2023-06-19" name="dei:EntityAddressCityOrTown">Holliston</ix:nonNumeric></span>, <span id="xdx_90A_edei--EntityAddressStateOrProvince_c20230619__20230619_zrOqouNEFxe1"><ix:nonNumeric contextRef="From2023-06-19to2023-06-19" name="dei:EntityAddressStateOrProvince">MA</ix:nonNumeric></span> <span id="xdx_908_edei--EntityAddressPostalZipCode_c20230619__20230619_zPHxbE2fKPLk"><ix:nonNumeric contextRef="From2023-06-19to2023-06-19" name="dei:EntityAddressPostalZipCode">01746</ix:nonNumeric></span></b></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of Principal Executive Offices) (Zip Code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2pt 0pt 0; text-align: center"><b><span id="xdx_908_edei--CityAreaCode_c20230619__20230619_zkJ5C1D2Z9N"><ix:nonNumeric contextRef="From2023-06-19to2023-06-19" name="dei:CityAreaCode">(508)</ix:nonNumeric></span> <span id="xdx_904_edei--LocalPhoneNumber_c20230619__20230619_zoERqTsm0vg4"><ix:nonNumeric contextRef="From2023-06-19to2023-06-19" name="dei:LocalPhoneNumber">893-8999</ix:nonNumeric></span></b></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant's telephone number, including area
code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed since
last report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 34pt 0pt 0">Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 0; text-align: right"></td>
    <td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--WrittenCommunications_c20230619__20230619_zp4m4znAzzB2"><ix:nonNumeric contextRef="From2023-06-19to2023-06-19" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="padding-left: 7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: right"></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--SolicitingMaterial_c20230619__20230619_zABmnYWgpkRb"><ix:nonNumeric contextRef="From2023-06-19to2023-06-19" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="padding-left: 7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: right"></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--PreCommencementTenderOffer_c20230619__20230619_z11JWF5kVqA9"><ix:nonNumeric contextRef="From2023-06-19to2023-06-19" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="padding-left: 7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: right"></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--PreCommencementIssuerTenderOffer_c20230619__20230619_zQfqecmqXFy5"><ix:nonNumeric contextRef="From2023-06-19to2023-06-19" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="padding-left: 7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.75in 0pt 6.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 1.75in; margin-bottom: 0pt">Securities registered pursuant to Section 12(b) of the
Act:</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border: Black 1pt solid; width: 37%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title of each class</span></td>
    <td style="border-top: Black 1pt solid; width: 30%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading Symbol(s)</span></td>
    <td style="border-top: Black 1pt solid; width: 33%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of each exchange on which registered</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--Security12bTitle_c20230619__20230619_zEEKg5IcAiL4"><ix:nonNumeric contextRef="From2023-06-19to2023-06-19" name="dei:Security12bTitle">Common Stock, $0.01 par value</ix:nonNumeric></span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--TradingSymbol_c20230619__20230619_z8MgMRxfm83g"><ix:nonNumeric contextRef="From2023-06-19to2023-06-19" name="dei:TradingSymbol">HBIO</ix:nonNumeric></span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--SecurityExchangeName_c20230619__20230619_ziYYGg05NiKk"><ix:nonNumeric contextRef="From2023-06-19to2023-06-19" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The NASDAQ Stock Market</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7pt 0pt 0">Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (&#167; 240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7pt 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7pt 0pt 0">Emerging growth company <span id="xdx_90B_edei--EntityEmergingGrowthCompany_c20230619__20230619_z6vfHeWmfaAl"><ix:nonNumeric contextRef="From2023-06-19to2023-06-19" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8pt 0pt 0">If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 4pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>Item&#160;5.02. Departure of Directors
or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">On June 20, 2023, Harvard Bioscience, Inc.
(the &#8220;Company&#8221;) issued a press release announcing the appointment of Jennifer Cote as the Company&#8217;s Chief Financial
Officer and Treasurer effective as of June 19, 2023. Ms. Cote previously served as the Company&#8217;s Interim Chief Financial Officer
and Treasurer. Ms. Cote will continue to serve as the Company&#8217;s principal financial officer and principal accounting officer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Ms. Cote, age 52, joined the Company as its
Vice President of Global Finance in May 2022 and has served as the Company&#8217;s Interim Chief Financial Officer and Treasurer since
January 2023. Prior to joining the Company, Ms. Cote held various financial, strategy, and operating roles of increasing responsibility
at Bose Corporation, a leading supplier of speakers, headphones, electronics and other related products for the consumer audio, automotive,
health, and professional audio market from 1999 to March 2022. She served as Bose&#8217;s Head of Global Business Services &#8211; Strategy
Enablement and Finance Services from September 2019 to March 2022 and Global Service Owner for Finance Services from December 2016 to
September 2019. Ms. Cote&#8217;s previous roles at Bose included Head of Finance for Bose&#8217;s Headphones Business Unit and Head of
Global Business Operations and Head of Finance for its Professional Systems Division. Earlier in her career, Ms. Cote held various positions
of increasing responsibility, including Audit Manager, at Arthur Andersen LLP. A Certified Public Accountant and Chartered Global Management
Accountant, Ms. Cote holds a Bachelor of Science in Accountancy from Villanova University.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In connection with her appointment, Ms. Cote and the Company entered
into an employment agreement (the &#8220;Agreement&#8221;) dated June 19, 2023 (the &#8220;Commencement Date&#8221;). The Agreement provides
for a one-year term, which term shall automatically be extended for one additional year on each anniversary of the Commencement Date unless,
not less than 90 days prior to each such date, either party shall have given written notice to the other that it does not wish to extend
the Agreement. Beginning on the Commencement Date, Ms. Cote will receive an annualized base salary (the &#8220;Base Salary&#8221;) of
$300,000. Beginning with fiscal year 2024, Ms. Cote will be eligible to receive annual target cash incentive compensation (the &#8220;Annual
Bonus&#8221;) of fifty percent (50%) of her Base Salary. Also beginning with fiscal year 2024, Ms. Cote will be eligible to receive annual
long-term incentive equity awards upon terms and conditions established by the Company&#8217;s Board of Directors or a Committee thereof.
Ms. Cote&#8217;s existing annual bonus awards for 2023 and existing equity awards will remain in effect according to their existing terms
and are not affected by the Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If Ms. Cote terminates her employment for good reason or if her employment
is terminated by the Company without cause (as such terms are defined in the Agreement), the Company will pay Ms. Cote an amount equal
to twelve (12) months of her Base Salary rate at date of termination, to be paid over a period of one (1) year, a pro-rata portion of
her Annual Bonus for the year of termination to be paid no later than March 15 of the following year, and a cash lump sum equal to the
value of her COBRA premiums for a period of one year following the date of termination. Upon the date of termination, all unvested equity
incentive awards shall be treated based on the terms of the underlying stock award agreements and the Company&#8217;s 2021 Incentive
Plan, as may be amended from time to time (the &#8220;2021 Incentive Plan&#8221;). If Ms. Cote terminates her employment for good reason
or if her employment is terminated by the Company without cause in connection with a change-in-control, the Company will pay Ms. Cote
a cash lump sum equal to twelve (12) months of the her Base Salary rate at the first event constituting a change in control and a cash
lump sum equal to the value of her COBRA premiums for a period of one year following the date of termination. Upon the date of termination,
all unvested equity incentive awards shall be treated based on the terms of the underlying stock award agreements and the 2021 Incentive
Plan. <span style="background-color: white">Receipt of the foregoing termination benefits will be subject to Ms. Cote&#8217;s execution
of a separation agreement, including certain restrictive covenants and a general release of all claims.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">There are no arrangements or understandings between Ms. Cote and any
other person pursuant to which Ms. Cote was selected as the Company&#8217;s Chief Financial Officer and Treasurer. There are no family
relationships between Ms. Cote and any director or executive officer of the Company, and she is not a party to any transaction required
to be disclosed pursuant to Item 404(a) of Regulation S-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The foregoing description of the principal terms of the Agreement is
qualified in its entirety by reference to the Agreement, a copy of which is filed as Exhibit 10.1 and incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 0px">&#160;</td>
    <td style="width: 96px"><span style="font-size: 10pt"><b>Item 8.01.</b></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt"><b>Other Events.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">On June 20, 2023, the Company issued a press
release announcing the appointment of Ms. Cote as the Company&#8217;s Chief Financial Officer and Treasurer. A copy of the press release
is attached hereto as Exhibit 99.1 and is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 0px">&#160;</td>
    <td style="width: 79px"><span style="font-size: 10pt"><b>Item 9.01</b></span></td>
    <td><span style="font-size: 10pt"><b>Financial Statements and Exhibits.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">(d) Exhibits.</span> &#160; &#160; &#160;</p>



<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid"><span style="font-size: 10pt"><b>Exhibit Number</b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: Black 1pt solid"><span style="font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 10%"><a href="exh_101.htm"><span style="font-size: 10pt">10.1</span></a></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 88%"><a href="exh_101.htm"><span style="font-size: 10pt">Employment Agreement between Jennifer Cote and the Company dated June 19, 2023</span></a></td></tr>
  <tr style="vertical-align: bottom">
    <td><a href="exh_991.htm"><span style="font-size: 10pt">99.1</span></a></td>
    <td>&#160;</td>
    <td><a href="exh_991.htm"><span style="font-size: 10pt">Press Release dated June 20, 2023</span></a></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Cover Page Interactive Data File (embedded within the XBRL document)</span></td></tr>
  </table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 25pt"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 4pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="2" style="text-align: left"><span style="font-size: 10pt"><b>HARVARD BIOSCIENCE, INC.</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 50%">&#160;</td>
    <td style="text-align: left; width: 30%">&#160;</td>
    <td style="width: 20%">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">Date: June 20, 2023</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt">/s/ John Fry</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="2" style="text-align: left"><span style="font-size: 10pt">John Fry</span></td>
    </tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="2" style="text-align: left"><span style="font-size: 10pt">Chief Legal Counsel and Secretary</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



<p style="margin: 0">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KgkAQhZ/Adxj2WkqN/rwrKYksQiK63XKMJd2R2e3vkXrLNiUaBobhnO8cIXyR0lJVyHCc5xnssW4qaRFyLJFRn9E5ktU6BndzvChjWWrbvj8wIcegY4a9cHJyQmu9K4NFDMGoH4770QCCSRxNYbYR3ldPSJeqQG2VrEDqAnZMDSu0kl9dwl4+SVP9aqsOyEaRjiHsBZ38higII9jSXT6IrwayLBGe344nUqZb8625GUs1LCqsXZfp0P96HxsMSU0= -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>exh_101.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>HARVARD BIOSCIENCE, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EMPLOYMENT AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">This EXECUTIVE EMPLOYMENT AGREEMENT (&ldquo;Agreement&rdquo;)
is made as of the date of last signature below (the &ldquo;Commencement Date&rdquo;) between Harvard Bioscience, Inc., a Delaware corporation
(the &ldquo;Company&rdquo;), and Jennifer Cote (&ldquo;Executive&rdquo;).&nbsp; For purposes of this Agreement the &ldquo;Company&rdquo;
shall refer to the Company and any of its predecessors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><I>WHEREAS</I>, the Company desires to employ
Executive and Executive desires to be employed by the Company on the terms contained herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><I>NOW, THEREFORE,</I>&nbsp;in consideration of
the mutual covenants and agreements herein contained and other good and valuable consideration, the receipt and sufficiency of which is
hereby acknowledged, the parties agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B><I>1. Employment.</I></B>&nbsp;The term of
this Agreement shall extend from the Commencement Date until one year from the Commencement Date; provided, however, that the term of
this Agreement shall automatically be extended for one additional year following the end of the term then in effect unless, not less than
90 days prior to each such date, either party gives written notice to the other that it does not wish to extend this Agreement; provided,
further, that if a Change in Control occurs during the original or extended term of this Agreement, the term of this Agreement shall,
notwithstanding anything in this sentence to the contrary, continue in effect for a period of not less than twelve (12)&nbsp;months beyond
the month in which the Change in Control occurred.&nbsp;The term of this Agreement shall be subject to termination as provided in Section
7 and may be referred to herein as the &ldquo;Period of Employment.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B><I>2. Position and Duties.&nbsp;</I></B>During
the Period of Employment, Executive shall serve as the Company&rsquo;s Chief Financial Officer, and shall have such powers and duties
as may from time to time be prescribed by the Board of Directors (the &ldquo;Board&rdquo;) or the Chief Executive Officer of the Company,
provided that such duties are consistent with Executive&rsquo;s position or other positions that Executive may hold from time to time.&nbsp;Executive
shall devote Executive&rsquo;s full working time and efforts to the business and affairs of the Company and shall work out of the Company&rsquo;s
offices in Holliston, MA. Notwithstanding the foregoing, Executive may serve on no more than two other boards of directors with the approval
of the Board as long as such service does not materially interfere with the performance of Executive&rsquo;s duties to the Company as
provided in this Agreement or otherwise breach any obligations of Executive to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B><I>3.&nbsp;Compensation and Related Matters.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt"><B><I>(a)</I></B>&nbsp;&nbsp;<B><I>Base Salary.</I></B>&nbsp;Beginning
on the Commencement Date, Executive&rsquo;s base salary shall be $25,000.00 per month (which annualizes to three hundred thousand dollars
($300,000.00)). Executive&rsquo;s base salary shall be re-determined each fiscal year during the term of this Agreement by the Board or
a Committee thereof, beginning with fiscal year 2024. The base salary in effect at any given time is referred to herein as &ldquo;Base
Salary.&rdquo; The Base Salary shall be payable in substantially equal installments on a bi-weekly or more frequent basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt"><B><I>(b) Incentive Compensation.&nbsp;</I></B>Commencing
with fiscal year 2024 and each fiscal year thereafter while this Agreement is in effect, Executive shall be eligible to receive target
cash incentive compensation of fifty percent (50%) of Executive&rsquo;s Base Salary paid during the fiscal year upon meeting objectives
as determined by the Board or a Committee thereof from time to time in their sole discretion. This annual bonus is referred to in this
Agreement as the &ldquo;Annual Bonus.&rdquo; Any such Annual Bonus that is earned shall be paid in accordance with the Company&rsquo;s
policies and procedures regarding the payment of cash incentive compensation, subject to Section 8 below. Executive shall also be eligible
to participate in such other incentive compensation plans as the Board or a Committee thereof shall determine from time to time for its
senior executive officers. Executive&rsquo;s existing Annual Bonus awards for fiscal year 2023 shall remain in effect according to their
existing terms and are unaffected by the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt"><B><I>(c) Equity Compensation.</I></B> Commencing
with fiscal year 2024 and each fiscal year thereafter while this Agreement is in effect, Executive shall be eligible to receive a long
term incentive equity award. All long term equity awards will be subject to the approval of the Board or a Committee thereof and will
be subject to such valuation methodologies and other terms and conditions as may be established by the Board or a Committee thereof in
connection with such awards in their sole discretion. Executive&rsquo;s existing equity awards shall remain in effect according to their
existing terms and are unaffected by the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt"><B><I>(d) Expenses.&nbsp;</I></B>Executive shall
be entitled to receive prompt reimbursement for all reasonable expenses incurred by Executive in performing services hereunder during
the Period of Employment, in accordance with the Company policies and procedures then in effect for its senior executive officers .</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;<B><I>(e)&nbsp; Other Benefits.</I></B>&nbsp;During
the Period of Employment, Executive shall be entitled to continue to participate in or receive benefits under all of the Company&rsquo;s
Employee Benefit Plans, or under plans or arrangements that provide no less favorable treatment to the Executive than the Employee Benefit
Plans provided to other, similarly situated, members of the Company&rsquo;s senior management.&nbsp;As used herein, the term &ldquo;Employee
Benefit Plans&rdquo; includes, without limitation, each pension and retirement plan; supplemental pension, retirement and deferred compensation
plan; savings and profit-sharing plan; stock ownership plan; stock purchase plan; stock option plan; life insurance plan; medical insurance
plan; disability plan; and health and accident plan or arrangement established and maintained by the Company on the date hereof or anytime
hereafter. The Executive's participation in the Employee Benefit Plans will be subject to the terms and conditions of each such Employee
Benefit Plans, including eligibility and compliance requirements, as well as any limitations imposed by applicable laws. To the extent
that the scope or nature of benefits described in this section is determined under the Company policies based on the seniority or tenure
of an employee&rsquo;s service, Executive shall be deemed to have tenure with the Company equal to the actual time of Executive&rsquo;s
service with the Company.&nbsp;During the Period of Employment, Executive shall be entitled to participate in or receive benefits under
any Employee Benefit Plans which may, in the future, be made available by the Company to its executives and key management employees,
subject to and on a basis consistent with the terms, conditions and overall administration of such Employee Benefit Plans.&nbsp;Any payments
or benefits payable to Executive under an Employee Benefit Plan referred to in this Subsection 3(d) in respect of any calendar year during
which Executive is employed by the Company for less than the whole of such year shall, unless otherwise provided in the applicable Employee
Benefit Plan, be prorated in accordance with the number of days in such calendar year during which Executive is so employed.&nbsp;Should
any such payments or benefits accrue on a fiscal (rather than calendar) year, then the proration shall be on the basis of a fiscal year
rather than calendar year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt"><B><I>(f)&nbsp; Vacations.&nbsp;</I></B><FONT STYLE="background-color: white">Executive
shall be entitled to the Company&rsquo;s senior leadership vacation plan which allows Executive to take time off as needed in each calendar
year.&#8239;Executive shall also be entitled to all paid holidays given by the Company to its executives.&nbsp;</FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt"><B><I>(g)&nbsp;Directors and Officers Insurance
and Indemnification</I></B>. The Company shall also carry reasonable and customary D&amp;O liability insurance coverage for the benefit
of its officers and directors, including Executive, during the term of this Agreement and for a customary tail period following the termination
of Executive&rsquo;s employment or service as a member of the Board. Executive shall be entitled to be indemnified by the Company consistent
with Company&rsquo;s Second Amended and Restated Certificate of Incorporation, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B><I>4.&nbsp;Unauthorized Disclosure.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt"><B><I>(a)&nbsp;Confidential Information.</I></B>&nbsp;Executive
acknowledges that in the course of Executive&rsquo;s employment with the Company (and, if applicable, its predecessors), Executive has
been allowed to become, and will continue to be allowed to become, acquainted with business affairs, information, trade secrets, and other
matters which are of a proprietary or confidential nature, including but not limited to the Company&rsquo;s and its affiliates&rsquo;
and predecessors&rsquo; operations, business opportunities, price and cost information, finance, customer information, business plans,
various sales techniques, manuals, letters, notebooks, procedures, reports, products, processes, services, and other confidential information
and knowledge concerning the Company and its affiliates&rsquo; and predecessors&rsquo; business (collectively the &ldquo;Confidential
Information&rdquo;).&nbsp;The Company agrees to provide on an ongoing basis such Confidential Information as the Company deems necessary
or desirable to aid Executive in the performance of Executive&rsquo;s duties.&nbsp;Executive understands and acknowledges that such Confidential
Information is confidential, and Executive agrees not to disclose such Confidential Information to anyone outside the Company except to
the extent that (i)&nbsp;Executive deems such disclosure or use reasonably necessary or appropriate in connection with performing Executive&rsquo;s
duties on behalf of the Company; (ii)&nbsp;Executive is required by order of a court of competent jurisdiction (by subpoena or similar
process) to disclose or discuss any Confidential Information, provided that in such case, Executive shall inform the Company of such event
within 24 hours of receiving notice of the court order, shall cooperate with the Company in attempting to obtain a protective order or
to otherwise restrict such disclosure, and shall only disclose Confidential Information to the minimum extent necessary to comply with
any such court order; (iii)&nbsp;such Confidential Information becomes generally known to and available for use in any industry in which
the Company does business (the &ldquo;Industry&rdquo;), other than as a result of any action or inaction by Executive; or (iv)&nbsp;such
information has been rightfully received by a member of the Industry or has been published in a form generally available to the Industry
prior to the date Executive proposes to disclose or use such information.&nbsp;Executive further agrees that Executive will not during
Executive&rsquo;s employment with the Company and/or at any time thereafter use such Confidential Information in competing, directly or
indirectly, with the Company.&nbsp;At such time as Executive shall cease to be employed by the Company, Executive will immediately turn
over to the Company all Confidential Information, including papers, documents, writings, electronically stored information, other property,
and all copies of them provided to or created by Executive during the course of Executive&rsquo;s employment with the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt"><B>&nbsp;</B></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt"><B><I>(b)&nbsp;Heirs, successors, and legal representatives.</I></B>&nbsp;The
foregoing provisions of this Section&nbsp;4 shall be binding upon Executive&rsquo;s heirs, successors, and legal representatives.&nbsp;The
provisions of this Section&nbsp;4 shall survive the termination of this Agreement for any reason.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt"><B><I>(c) Defend Trade Secrets Act Whistleblower
Immunity</I>.&nbsp;</B>Executive acknowledges and understand that Executive shall not be held criminally or civilly liable under any Federal
or State trade secret law for the disclosure of a trade secret that (A) is made (i) in confidence to a Federal, State, or local government
official, either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected
violation of law; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under
seal. Also, if Executive files a lawsuit for retaliation by an employer for reporting a suspected violation of law, Executive may disclose
the trade secret to Executive&rsquo;s attorney and use the trade secret information in the court proceeding, provided that Executive files
any document containing the trade secret under seal and do not disclose the trade secret, except pursuant to court order.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B><I>5.&nbsp;Covenant Not to Compete or Solicit
or Hire.</I></B>&nbsp;Executive acknowledges that the confidential and proprietary information of the Company is a special, valuable,
and unique asset of the Company and Executive understands and acknowledges that the Company has invested, and continues to invest, substantial
time, money, and specialized knowledge into developing its resources, creating a customer base, generating customer and potential customer
lists, and training its employees. Executive understands that the nature of Executive&rsquo;s position gives the Executive access to and
knowledge of this confidential and proprietary information and places the Employee in a position of trust and confidence with the Company.
In consideration for Executive&rsquo;s employment by the Company under the terms provided in this Agreement, and more particularly the
terms set forth in Section 3(c), and as a means to aid in the performance and enforcement of the terms of the provisions of Section&nbsp;4,
Executive agrees that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 48.95pt"></TD><TD STYLE="width: 18pt"><B><I>(a)</I></B></TD><TD>during the term of Executive&rsquo;s employment with the Company and for a period of twelve (12)&nbsp;months thereafter (the &ldquo;Restricted
Period&rdquo;), Executive will not, directly or indirectly, as an owner, director, principal, agent, officer, employee, partner, consultant,
servant, or otherwise, carry on, operate, manage, control, or become involved in any manner with any business, operation, corporation,
partnership, association, agency, or other person or entity which is engaged in a business that produces or develops products that compete
or may compete directly with any products (i) which are produced or being developed by the Company or any affiliate of the Company or
(ii) which the Company or any affiliate of the Company has active plans to produce or develop as of the date of Executive&rsquo;s termination
of employment with the Company, in any area or territory in which the Company or any affiliate of the Company conducts or has active plans
to conduct operations as of the date of the Executive&rsquo;s termination; provided that, for (i) and (ii) that Executive provided services
or operations to the Company regarding such products (or about which operations Executive had material presence or influence) within the
two years prior to Executive&rsquo;s termination of employment with the Company; provided, however, that the foregoing shall not prohibit
Executive from owning up to one percent (1%)&nbsp;of the outstanding stock of a publicly held company engaged in the Industry. Executive
acknowledges and agrees that the terms of this Agreement constitute mutually agreed consideration for the provisions of this Section 5(a).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt"><B><I>(b)&nbsp;</I></B>during the Restricted
Period, regardless of the reason for termination of employment, Executive will not directly or indirectly solicit or induce any present
or future employee of the Company or any affiliate of the Company to accept employment with Executive or with any business, operation,
corporation, partnership, association, agency, or other person or entity with which Executive may be associated, and Executive will not
hire or employ or cause any business, operation, corporation, partnership, association, agency, or other person or entity with which Executive
may be associated to hire or employ any present or future employee of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Should Executive violate any of the provisions
of this Section, then in addition to all other rights and remedies available to the Company at law or in equity, the duration of this
covenant shall automatically be extended for the period of time from which Executive began such violation until Executive permanently
ceases such violation. Executive acknowledges and agrees that the terms and conditions of this Section 5 are reasonable with respect to
its duration, geographic area and scope. In the event the post-employment restrictions of Section 5 are held by a court of competent jurisdiction,
in any respect, to be an unreasonable restriction upon Executive, then it is the intent of the parties that the court so holding reduce
the territory, time, or activity to which pertains, or otherwise reasonably modify the covenant to the extent necessary to render this
covenant enforceable by said court, in accordance with the intent of the parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B><I>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Remedies.</I></B>&nbsp;Executive
acknowledges that full compliance with the terms of this Agreement is necessary to protect the significant value of the Confidential Information
and the customer and business goodwill of the Company. Executive acknowledges that if Executive breaches this Agreement, the Company will
be irreparably harmed and money damages will not be an adequate remedy. As a result, Executive agrees that, in the event Executive breaches
or threatens to breach any of the terms or provisions of this Agreement, the Company shall be entitled to a preliminary or permanent injunction,
without posting a bond or other security, in order to prevent the continuation of such harm. Executive acknowledges that nothing in this
Agreement will prohibit the Company from also pursuing any other remedy and all remedies are cumulative. The parties intend that the Company
shall be entitled to a full one-year period of post-employment conduct by the Executive that complies with this Agreement. Executive therefore
agrees that the one-year restrictive period under Sections 5(a) and (b) shall be respectively tolled for the same period that Executive
engages in the prohibited conduct prior to the Company&rsquo;s discovery of such violation. If Executive breaches Executive&rsquo;s fiduciary
duty to the Company or unlawfully takes, physically, or electronically, property belonging to the Company, the one year restrictive period
set forth in Sections 5(a) and (b) shall be extended to twenty-four (24) months.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B><I>7.&nbsp;Termination.</I></B>&nbsp;Executive&rsquo;s
employment hereunder may be terminated without any breach of this Agreement under the following circumstances:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt"><B><I>(a)&nbsp;Death.&nbsp;</I></B>Executive&rsquo;s
employment hereunder shall terminate upon Executive&rsquo;s death.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt"><B><I>(b)&nbsp;Disability.&nbsp;</I></B>If, as
a result of Executive&rsquo;s incapacity due to physical or mental illness, Executive shall have been absent from Executive&rsquo;s duties
hereunder on a full-time basis for one hundred eighty (180)&nbsp;calendar days in the aggregate in any twelve (12)&nbsp;month period,
the Company may terminate Executive&rsquo;s employment hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt"><B><I>(c)&nbsp;Termination by Company For Cause.</I></B>&nbsp;At
any time during the Period of Employment, the Company may terminate Executive&rsquo;s employment hereunder for Cause if such termination
is approved by not less than a majority of the Board at a meeting of the Board called and held for such purpose.&nbsp;For purposes of
this Agreement, &ldquo;Cause&rdquo; shall mean:&nbsp;(A)&nbsp;conduct by Executive constituting an act of willful misconduct in connection
with the performance of Executive&rsquo;s duties, including, without limitation, misappropriation of funds or property of the Company
or any of its affiliates; (B)&nbsp;criminal or civil conviction of Executive, a plea of nolo contendere by Executive or conduct by Executive
that would reasonably be expected to result in injury to the reputation of the Company if Executive were retained in Executive&rsquo;s
position with the Company, including, without limitation, conviction of a felony involving moral turpitude; (C)&nbsp;continued, willful
and deliberate non-performance by Executive of Executive&rsquo;s duties hereunder (other than by reason of Executive&rsquo;s physical
or mental illness, incapacity or disability); (D)&nbsp;a breach by Executive of any of the provisions contained in Sections 4 and 5 of
this Agreement; or (E)&nbsp;a violation by Executive of the Company&rsquo;s material employment policies which has continued following
written notice of such violation from the Board. If the Company determines that any alleged Cause under subparts 7(c)(A), (D), and (E)
is reasonably susceptible to being cured, the Company shall provide Executive with written notice specifying the basis for the alleged
Cause and Executive shall have thirty (30) days to cure such Cause.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt"><B><I>(d)&nbsp;Termination Without Cause.</I></B>&nbsp;At
any time during the Period of Employment, the Company may terminate Executive&rsquo;s employment hereunder without Cause.&nbsp;Any termination
by the Company of Executive&rsquo;s employment under this Agreement which does not constitute a termination for Cause under Subsection
7(c) or result from the death or disability of the Executive under Subsections 7(a) or (b)&nbsp;shall be deemed a termination without
Cause.&nbsp;If the Company provides notice to Executive under Section 1 that it does not wish to extend the Period of Employment, including
a non-renewal at the end of the initial term or any renewal period, such action shall be deemed a termination without Cause.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt"><B><I>(e)&nbsp;Termination by Executive.</I></B>&nbsp;At
any time during the Period of Employment, Executive may terminate Executive&rsquo;s employment hereunder for any reason, including but
not limited to Good Reason.&nbsp;If Executive provides notice to the Company under Section&nbsp;1 that Executive does not wish to extend
the Period of Employment, such action shall be deemed a voluntary termination by Executive and one without Good Reason.&nbsp;For purposes
of this Agreement, &ldquo;Good Reason&rdquo; shall mean that Executive has complied with the &ldquo;Good Reason Process&rdquo; (hereinafter
defined) following the occurrence of any of the following events:&nbsp;(A)&nbsp;a substantial diminution or other substantial adverse
change, not consented to by Executive (or caused by Executive&rsquo;s disability as elsewhere provided herein), in the nature or scope
of Executive&rsquo;s responsibilities, authorities, powers, functions, duties or reporting relationship; (B) an involuntary reduction
in Executive&rsquo;s Base Salary except for across-the-board reductions similarly affecting all or substantially all executive officers;
(C)&nbsp;a breach by the Company of any of its other material obligations under this Agreement and the failure of the Company to cure
such breach within thirty (30)&nbsp;days after written notice thereof by Executive; (D)&nbsp;the involuntary relocation of the Company&rsquo;s
offices at which Executive is principally employed on the Commencement Date or the involuntary relocation of the offices of Executive&rsquo;s
primary workgroup to a location more than 30 miles from such offices, or the requirement by the Company that Executive be based anywhere
other than the Executive&rsquo;s principal work location on the Commencement Date on an extended basis, except for required travel on
the Company&rsquo;s business; or (E)&nbsp;the failure of the Company to obtain the agreement from any successor to the Company to assume
and agree to perform this Agreement as required by Section 12 (each of which is hereinafter referred to as a &ldquo;Good Reason event&rdquo;).&nbsp;&ldquo;Good
Reason Process&rdquo; shall mean that (i)&nbsp;Executive reasonably determines in good faith that a &ldquo;Good Reason&rdquo; event has
occurred; (ii)&nbsp;Executive notifies the Company in writing of the occurrence of the Good Reason event by no later than sixty (60) days
after the initial occurrence of the event or condition constituting Good Reason; (iii)&nbsp;Executive cooperates in good faith with the
Company&rsquo;s efforts, for a period not less than ninety (90)&nbsp;days following such notice, to modify Executive&rsquo;s employment
situation; and (iv)&nbsp;notwithstanding such efforts, one or more of the Good Reason events continues to exist and has not been modified
in a manner acceptable to Executive.&nbsp;If the Company cures the Good Reason event during the ninety (90)&nbsp;day period, Good Reason
shall be deemed not to have occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt"><B><I>(f)&nbsp;Notice of Termination.</I></B>&nbsp;Except
for termination as specified in Subsection 7(a), any termination of Executive&rsquo;s employment by the Company or any such termination
by Executive shall be communicated by written Notice of Termination to the other party hereto and shall be effective on the Date of Termination
(as defined below).&nbsp;For purposes of this Agreement, a &ldquo;Notice of Termination&rdquo; shall mean a notice which shall indicate
the specific termination provision in this Agreement relied upon.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt"><B><I>(g)&nbsp;Date of Termination.</I></B>&nbsp;&ldquo;Date
of Termination&rdquo; shall mean:&nbsp;(A)&nbsp;if Executive&rsquo;s employment is terminated by Executive&rsquo;s death, the date of
Executive&rsquo;s death; (B)&nbsp;if Executive&rsquo;s employment is terminated on account of disability under Subsection 7(b) or by the
Company for Cause under Subsection 7(c), the date on which Notice of Termination is given or such later date as the Company may specify
in the Notice of Termination; (C)&nbsp;if Executive&rsquo;s employment is terminated by the Company under Subsection 7(d), sixty (60)&nbsp;days
after the date on which a Notice of Termination is given or such later date as the Company may specify in the Notice of Termination (or,
if such termination occurs as a result of the Company providing notice to Executive under Section&nbsp;1 that it does not wish to extend
the Period of Employment, the date of the expiration of the current term of this Agreement); and (D)&nbsp;if Executive&rsquo;s employment
is terminated by Executive under Subsection 7(e), thirty (30)&nbsp;days after the date on which a Notice of Termination is given or, if
such termination is without Good Reason, such later date up to sixty (60)&nbsp;days after the date on which such Notice of Termination
is given as Executive may specify in the Notice of Termination (or, if such termination occurs as a result of the Company providing notice
to Executive under Section&nbsp;1 that it does not wish to extend the Period of Employment, the date of the expiration of the current
term of this Agreement).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt"><B><I>(h) Separation from Service</I>. Notwithstanding
anything herein to the contrary, to the extent necessary to comply with Section 409A of the Internal Revenue Code of 1986, as amended
(&ldquo;Code&rdquo;), no event shall constitute a &ldquo;termination of employment&rdquo; in this Agreement, unless such event is also
a &ldquo;separation from service,&rdquo; as that term is defined for purposes of Section 409A and Treasury Regulation &sect;1.409A-3(a)(1).</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt"><B><I>(i) Resignation of All Other Positions</I></B>.
Upon termination of the Executive's employment hereunder for any reason, the Executive shall be deemed to have resigned from all positions
that the Executive holds as an officer or member of the board of directors (or a committee thereof) of the Company or any of its affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B><I>8.&nbsp;Compensation Upon Termination or
During Disability.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt"><B><I>(a)&nbsp;Death.&nbsp;</I></B>If Executive&rsquo;s
employment terminates by reason of Executive&rsquo;s death, the Company shall, within sixty (60)&nbsp;days of death, pay in a lump sum
to such person as Executive shall designate in a notice filed with the Company or, if no such person is designated, to Executive&rsquo;s
estate, Executive&rsquo;s accrued and unpaid Base Salary to the date of Executive&rsquo;s death, accrued and unused vacation, and if to
the extent required by law, any bonuses or other compensation actually earned for periods ended prior to the date of Executive&rsquo;s
death (including any Annual Bonus for fiscal years ended prior to the date of death, if earned and not already paid) (collectively, the
&ldquo;Accrued Obligations&rdquo;). Upon the death of Executive, all unvested equity incentive awards (i.e., stock options or other stock-based
equity awards) shall be treated based on the terms of the underlying stock award agreements and 2021 Incentive Plan, as may be amended
from time to time.&nbsp; Within ninety (90)&nbsp;days following the Date of Termination (but in no event later than March 15 of the calendar
year immediately after the calendar year in which the Date of Termination occurs), the Company shall pay as provided above a cash lump
sum equal to the value of COBRA premiums for a period of one (1)&nbsp;year following the Date of Termination that may be used by the Executive&rsquo;s
spouse and dependents to pay for health insurance coverage that is substantially similar to coverage they received prior to the Date of
Termination.&nbsp; In addition to the foregoing, any payments to which Executive&rsquo;s spouse, beneficiaries, or estate may be entitled
under any employee benefit plan shall also be paid in accordance with the terms of such plan or arrangement.&nbsp;The payments made under
this section shall fully discharge the Company&rsquo;s obligations hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt"><B><I>(b)&nbsp;Disability.</I></B>&nbsp;During
any period that Executive fails to perform Executive&rsquo;s duties hereunder as a result of incapacity due to physical or mental illness,
Executive shall continue to receive Executive&rsquo;s Base Salary, until Executive&rsquo;s employment is terminated due to disability
in accordance with Subsection 7(b) or until Executive terminates Executive&rsquo;s employment in accordance with Subsection 7(e), whichever
first occurs.&nbsp;Upon the Date of Termination by reason of Executive&rsquo;s disability, all unvested equity incentive awards shall
be treated based on the terms of the underlying stock award agreements and the 2021 Incentive Plan, as may be amended from time to time.&nbsp;
If there is a dispute about whether Executive is disabled, the parties shall use the procedure described in Section 16, below, to resolve
such dispute. If Executive&rsquo;s employment is terminated due to disability in accordance with Subsection 7(b), then the Company shall
pay Executive all Accrued Obligations through the Date of Termination in a lump-sum payment by no later than sixty (60) days after the
Date of Termination. Within ninety (90)&nbsp;days following the Date of Termination (but in no event later than March 15 of the calendar
year immediately after the calendar year in which the Date of Termination occurs), the Company shall pay to Executive a cash lump sum
equal to the value of COBRA premiums for a period of one (1)&nbsp;year following the Date of Termination that may be used by Executive
to pay for health insurance coverage that is substantially similar to the coverage Executive and Executive&rsquo;s eligible dependents
received prior to the Date of Termination.&nbsp; Upon termination due to death prior to the termination first to occur as specified in
the preceding sentence, Subsection 8(a) shall apply.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt"><B><I>(c)&nbsp;Resignation other than for Good
Reason.</I></B>&nbsp;If Executive voluntarily resigns from employment other than for Good Reason as provided in Subsection 7(e), then
the Company shall pay Executive all Accrued Obligations through the Date of Termination in a lump-sum payment by no later than sixty (60)
days after the Date of Termination. Thereafter, the Company shall have no further obligations to Executive except as otherwise expressly
provided under this Agreement, provided any such termination shall not adversely affect or alter Executive&rsquo;s rights under any employee
benefit plan of the Company in which Executive, at the Date of Termination, has a vested interest, unless otherwise provided in such employee
benefit plan or any agreement or other instrument attendant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt"><B><I>(d)&nbsp;Termination by Executive for Good
Reason or by the Company without Cause.</I></B>&nbsp;Subject to the terms of Section 19(a), and subject to the terms of this section,
if the Executive&rsquo;s employment is terminated for Good Reason as provided in Subsection 7(e) or without Cause as provided in Subsection
7(d), then the Company shall pay Executive all Accrued Obligations through the Date of Termination in a lump-sum payment by no later than
sixty (60) days after the Date of Termination.&nbsp;In addition, subject to the Executive&rsquo;s execution of a general release of claims
in the form attached hereto as&nbsp;<U>Exhibit A</U>&nbsp;within 21 days after the Date of Termination and the expiration of the seven-day
revocation period applicable thereto without the Executive revoking Executive&rsquo;s acceptance of such general release, commencing on
the last day of the period for signing and revoking the general release of claims generally in the form set forth in Exhibit A hereof
(&ldquo;Release&rdquo;):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">&nbsp;</P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">(i)&nbsp;the Company shall pay Executive
an amount equal to twelve (12) months of the Executive&rsquo;s Base Salary rate at the Date of Termination (the &ldquo;Severance Amount&rdquo;).
The Severance Amount shall be paid in cash in equal installments over the period of one year from the date of commencement in accordance
with the Company&rsquo;s standard payroll procedures.&nbsp; Notwithstanding the foregoing, if the Executive breaches any of the provisions
contained in Sections 4 and 5 of this Agreement, all payments of the Severance Amount shall immediately cease and the entire Severance
Amount shall be forfeited and become repayable to the Company to the extent paid. Furthermore, in the event Executive terminates Executive&rsquo;s
employment for Good Reason as provided in Subsection 7(e), Executive shall be entitled to the Severance Amount only if Executive provides
the Notice of Termination provided for in Subsection 7(f) within thirty (30)&nbsp;days after Executive has complied with the Good Reason
Process;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">(ii) on or before March 15 of the
calendar year immediately after the calendar year in which the Date of Termination occurs, the Company shall (a) reasonably determine
what Annual Bonus the Executive would have received had Executive remained employed throughout the fiscal year in which the Date of Termination
occurs, and (b) if any such Annual Bonus would have been earned, then pay the Executive a pro rata portion of such determined Annual Bonus
by a lump-sum cash payment (where the pro rata amount is based on the number of days that Executive was employed during the applicable
fiscal year);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">(iii)&nbsp;upon the Date of Termination,
all unvested equity incentive awards shall be treated based on the terms of the underlying stock award agreements and the 2021 Incentive
Plan, as may be amended from time to time; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">(iv)&nbsp;in addition to any other
benefits to which Executive may be entitled in accordance with the Company&rsquo;s then existing severance policies, within ninety (90)&nbsp;days
following the Date of Termination (but in no event later than March 15 of the calendar year immediately after the calendar year in which
the Date of Termination occurs), the Company shall pay a cash lump sum equal to the value of COBRA premiums for a period of one (1)&nbsp;year
following the Date of Termination that may be used by Executive to pay for health insurance coverage that is substantially similar to
the coverage Executive and Executive&rsquo;s eligible dependents received prior to the Date of Termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt"><B><I>(e)&nbsp;Termination for Cause.</I></B>&nbsp;If
Executive&rsquo;s employment is terminated by the Company for Cause as provided in Subsection 7(c), then the Company shall pay Executive
all Accrued Obligations through the Date of Termination in a lump-sum payment by no later than sixty (60) days after the Date of Termination.&nbsp;Thereafter,
the Company shall have no further obligations to Executive except as otherwise expressly provided under this Agreement, provided any such
termination shall not adversely affect or alter Executive&rsquo;s rights under any employee benefit plan of the Company in which Executive,
at the Date of Termination, has a vested interest, unless otherwise provided in such employee benefit plan or any agreement or other instrument
attendant thereto.&nbsp;In addition, all stock options held by Executive as of the Date of Termination shall immediately terminate and
be of no further force and effect, and all other stock-based grants and awards shall be canceled or terminated in accordance with their
terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Nothing contained in the foregoing Subsections 8(a) through 8(e) shall
be construed so as to affect Executive&rsquo;s rights or the Company&rsquo;s obligations relating to agreements or benefits which are
unrelated to termination of employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B><I>9.&nbsp;Change in Control Payment.&nbsp;</I></B>The
provisions of this Section 9 set forth certain terms of an agreement reached between Executive and the Company regarding Executive&rsquo;s
rights and obligations upon the occurrence of a Change in Control of the Company.&nbsp;These provisions are intended to assure and encourage
in advance Executive&rsquo;s continued attention and dedication to Executive&rsquo;s assigned duties and Executive&rsquo;s objectivity
during the pendency and after the occurrence of any such event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B><I>(a)&nbsp;Change in Control.</I></B>&nbsp;If
within three (3) months prior to, or twelve (12)&nbsp;months after the occurrence of the first event constituting a Change in Control,
Executive&rsquo;s employment is terminated by the Company without Cause as provided in Subsection 7(d) or Executive terminates Executive&rsquo;s
employment for Good Reason as provided in Subsection 7(e), then, subject to the terms of Section 19(a), and subject to the Executive&rsquo;s
executing a general release of claims in the form attached hereto as&nbsp;<U>Exhibit&nbsp;</U>A within 21 days after the Date of Termination
and the expiration of the seven-day revocation period applicable thereto without the Executive revoking Executive&rsquo;s acceptance of
such general release, commencing on the last day of the period for signing and revoking the general release of claims in the form set
forth in Exhibit A hereof:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In lieu of any amounts otherwise payable pursuant to Subsection 8(d)(i), the Company shall pay Executive a single lump sum in cash
equal to twelve (12) months of the Executive&rsquo;s Base Salary rate at the first event constituting a Change in Control;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="background-color: white">&#8239;upon the Date of Termination, all unvested equity incentive awards shall be treated
based on the terms of the underlying stock award agreements and the 2021 Incentive Plan, as may be amended from time to time; </FONT>and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">(ii) within ninety (90)&nbsp;days following the
Date of Termination, the Company shall pay a cash lump sum equal to the value of COBRA premiums for a period of twelve (12) months following
the Date of Termination that may be used by Executive to pay for health insurance coverage that is substantially similar to the coverage
Executive and Executive&rsquo;s eligible dependents received prior to the Date of Termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt"><B><I>(b)&nbsp;Definitions.</I></B>&nbsp;For
purposes of this Section&nbsp;9, the following terms shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&ldquo;Change in Control&rdquo;</B>&nbsp;shall
mean any of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">(a)&nbsp;a change in effective control
consistent with Regulation &sect;1.409A-3(i)(5)(vi) such that any &ldquo;person,&rdquo; as such term is used in Sections 13(d) and 14(d)
of the Securities Exchange Act of 1934, as amended (the &ldquo;Act&rdquo;) (other than the Company, any of its subsidiaries, or any trustee,
fiduciary or other person or entity holding securities under any employee benefit plan or trust of the Company or any of its subsidiaries),
together with all &ldquo;affiliates&rdquo; and &ldquo;associates&rdquo; (as such terms are defined in Rule 12b-2 under the Act) of such
person, shall become the &ldquo;beneficial owner&rdquo; (as such term is defined in Rule 13d-3 under the Act), directly or indirectly,
of securities of the Company representing more than fifty (50) percent (50%)&nbsp; of the combined voting power of the Company&rsquo;s
then outstanding securities having the right to vote in an election of the Company&rsquo;s Board (&ldquo;Voting Securities&rdquo;) (other
than as a result of an acquisition of securities directly from the Company); or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">(b)&nbsp;a change in effective control
consistent with Regulation &sect;1.409A-3(i)(5)(vi) such that persons who, as of the Commencement Date, constitute the Company&rsquo;s
Board (the &ldquo;Incumbent Directors&rdquo;) cease for any reason, including, without limitation, as a result of a tender offer, proxy
contest, merger or similar transaction, to constitute at least a majority of the Board, provided that any person becoming a director of
the Company subsequent to the Commencement Date shall be considered an Incumbent Director if such person&rsquo;s election was approved
by or such person was nominated for election by a vote of at least a majority of the Incumbent Directors; but provided further, that any
such person whose initial assumption of office is in connection with an actual or threatened election contest relating to the election
of members of the Board or other actual or threatened solicitation of proxies or consents by or on behalf of a person other than the Board,
including by reason of agreement intended to avoid or settle any such actual or threatened contest or solicitation, shall not be considered
an Incumbent Director; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">(c)&nbsp;a change in ownership consistent
with Regulation &sect;1.409A-3(i)(5)(v) and (vii) such that the stockholders of the Company shall approve (A)&nbsp;any consolidation or
merger of the Company where the stockholders of the Company, immediately prior to the consolidation or merger, would not, immediately
after the consolidation or merger, beneficially own (as such term is defined in Rule 13d-3 under the Act), directly or indirectly, shares
representing in the aggregate more than fifty percent (50%)&nbsp;of the voting shares of the Company issuing cash or securities in the
consolidation or merger (or of its ultimate parent corporation, if any), (B)&nbsp;any sale, exchange or other transfer (in one transaction
or a series of transactions contemplated or arranged by any party as a single plan) of all or substantially all of the assets of the Company
or (C)&nbsp;any plan or proposal for the liquidation or dissolution of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 76.5pt"><B>&nbsp;</B></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 76.5pt"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt"><B>(c)&nbsp;<I>Section 280G.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: 0.5in">(i) Notwithstanding any other provision
of this Agreement or any other plan, arrangement or agreement to the contrary, if any of the payments or benefits provided or to be provided
by the Company or its affiliates to the Executive or for the Executive's benefit pursuant to the terms of this Agreement or otherwise
(&quot;<B>Covered Payments</B>&quot;) constitute parachute payments (&quot;<B>Parachute Payments</B>&quot;) within the meaning of Section
280G of the Code and would, but for this Section 9(c) be subject to the excise tax imposed under Section 4999 of the Code (or any successor
provision thereto) or any similar tax imposed by state or local law or any interest or penalties with respect to such taxes (collectively,
the &quot;<B>Excise Tax</B>&quot;), then prior to making the Covered Payments, a calculation shall be made comparing (I) the Net Benefit
(as defined below) to the Executive of the Covered Payments after payment of the Excise Tax to (II) the Net Benefit to the Executive of
the Covered Payments if the Covered Payments are limited to the extent necessary to avoid being subject to the Excise Tax. In the event
that the amount calculated under (I) above is less than the amount under (II) above, then the Covered Payments shall be reduced to the
minimum extent necessary to ensure that no portion of the Covered Payments is subject to the Excise Tax.&nbsp;<B>&quot;Net Benefit&quot;&nbsp;</B>shall
mean the present value of the Covered Payments net of all federal, state, local, foreign income, employment and excise taxes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: 0.5in">(ii) Any such reduction shall be made
in accordance with Section 409A of the Code and the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: 0.5in">(I) the Covered Payments which do not
constitute nonqualified deferred compensation subject to Section 409A of the Code shall be reduced first; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: 0.5in">(II) all other Covered Payments shall
then be reduced as follows: (A) cash payments shall be reduced before non-cash payments; and (B) payments to be made on a later payment
date shall be reduced before payments to be made on an earlier payment date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: 0.5in">(iii) Unless the Company and Executive
otherwise agree in writing, any determination required under this Section 9(c) shall be made in writing in good faith on the advice of
an accounting firm selected by the Company immediately before a Change in Control (such firm or other party mutually agreed in writing
by the Company and Executive, the &ldquo;Accountants&rdquo;), which shall provide detailed supporting calculations to the Company and
the Executive as requested by the Company or the Executive. For purposes of making the calculations and determinations required by this
Section 9(c), the Accountants may rely on reasonable, good faith assumptions and approximations concerning the application of Section
280G and Section 4999 of the Code. The Accountants' determinations shall be final and binding on the Company and the Executive. The Company
shall be responsible for all fees and expenses incurred by the Accountants in connection with the calculations required by this Section
9(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B><I>10. Reserved.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B><I>11.&nbsp;Notice.</I></B>&nbsp;For purposes
of this Agreement, notices and all other communications provided for in the Agreement shall be in writing and shall be deemed to have
been duly given when delivered or mailed by United States certified mail, return receipt requested, postage prepaid, addressed as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">if to the Executive:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt">At Executive&rsquo;s home address as shown</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt">in the Company&rsquo;s personnel records;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt">&nbsp;</P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt">if to the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt">Harvard Bioscience, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt">84 October Hill Road</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt">Holliston, MA 01746&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">or to such other address as either party may have furnished to the
other in writing in accordance herewith, except that notices of change of address shall be effective only upon receipt.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B><I>12.&nbsp;Successor to Company.</I></B>&nbsp;The
Company shall require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially
all of the business or assets of the Company expressly to assume and agree to perform this Agreement to the same extent that the Company
would be required to perform it if no succession had taken place.&nbsp;Failure of the Company to obtain an assumption of this Agreement
at or prior to the effectiveness of any succession shall be a breach of this Agreement and shall constitute Good Reason if the Executive
elects to terminate employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B><I>13.&nbsp;Miscellaneous.</I></B>&nbsp;No
provisions of this Agreement may be modified, waived, or discharged unless such waiver, modification, or discharge is agreed to in writing
and signed by Executive and such officer of the Company as may be specifically designated by the Board.&nbsp;No waiver by either party
hereto of, or compliance with, any condition or provision of this Agreement to be performed by such other party shall be deemed a waiver
of similar or dissimilar provisions or conditions at the same or at any prior or subsequent time.&nbsp;No agreements or representations,
oral or otherwise, express or implied, unless specifically referred to herein, with respect to the subject matter hereof have been made
by either party which are not set forth expressly in this Agreement.&nbsp;The validity, interpretation, construction, and performance
of this Agreement shall be governed by the laws of the Massachusetts (without regard to principles of conflicts of laws).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B><I>14.&nbsp;Validity.</I></B>&nbsp;The invalidity
or unenforceability of any provision or provisions of this Agreement shall not affect the validity or enforceability of any other provision
of this Agreement, which shall remain in full force and effect. The invalid portion of this Agreement, if any, shall be modified by any
court having jurisdiction to the extent necessary to render such portion enforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B><I>15.&nbsp;Counterparts.</I></B>&nbsp;This
Agreement may be executed in several counterparts, each of which shall be deemed to be an original but all of which together will constitute
one and the same instrument.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B><I>16.&nbsp;Arbitration; Other Disputes.</I></B>&nbsp;In
the event of any dispute or controversy arising under or in connection with this Agreement, the parties shall first promptly try in good
faith to settle such dispute or controversy by mediation under the applicable rules of the American Arbitration Association before resorting
to arbitration.&nbsp;In the event such dispute or controversy remains unresolved in whole or in part for a period of thirty (30)&nbsp;days
after it arises, the parties will settle any remaining dispute or controversy exclusively by final, binding, and confidential arbitration
in Boston, MA, in accordance with the rules of the American Arbitration Association then in effect.&nbsp;Judgment may be entered on the
arbitrator&rsquo;s award in any court having jurisdiction.&nbsp;Notwithstanding the above, the Company shall be entitled to seek a restraining
order or injunction or other equitable relief without the need to post a bond or provide other security in the Superior Court or business
litigation session located in Suffolk County or at the option of the Company, in the county where the Executive resides to prevent any
continuation of any violation of Section 4, 5, 24, 25 or 26 hereof.&nbsp;Furthermore, should a dispute occur concerning Executive&rsquo;s
mental or physical capacity as described in Subsection 7(b), 7(c) or 8(b), a doctor selected by Executive and a doctor selected by the
Company shall be entitled to examine Executive.&nbsp;If the opinion of the Company&rsquo;s doctor and Executive&rsquo;s doctor conflict,
the Company&rsquo;s doctor and Executive&rsquo;s doctor shall together agree upon a third doctor, whose opinion shall be binding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B><I>17.&nbsp;Third-Party Agreements and Rights.&nbsp;</I></B>Executive
represents to the Company that Executive&rsquo;s execution of this Agreement, Executive&rsquo;s employment with the Company and the performance
of Executive&rsquo;s proposed duties for the Company will not violate any obligations Executive may have to any employer or other party,
and Executive will not bring to the premises of the Company any copies or other tangible embodiments of confidential information belonging
to or obtained from any such previous employment or other party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B><I>18.&nbsp;Litigation and Regulatory Cooperation.</I></B>&nbsp;During
and after Executive&rsquo;s employment, Executive shall reasonably cooperate with the Company in the defense or prosecution of any claims
or actions now in existence or which may be brought in the future against or on behalf of the Company which relate to events or occurrences
that transpired while Executive was employed by the Company so long as such cooperation does not materially and adversely affect Executive
or expose Executive to an increased probability of civil or criminal litigation.&nbsp;Executive&rsquo;s cooperation in connection with
such claims or actions shall include, but not be limited to, being available to meet with counsel to prepare for discovery or trial and
to act as a witness on behalf of the Company at mutually convenient times.&nbsp;During and after Executive&rsquo;s employment, Executive
also shall cooperate fully with the Company in connection with any investigation or review of any federal, state or local regulatory authority
as any such investigation or review relates to events or occurrences that transpired while Executive was employed by the Company.&nbsp;The
Company shall also provide Executive with compensation on an hourly basis at a rate equivalent to the hourly rate of the Executive&rsquo;s
last annual Base Salary calculated using a forty&nbsp;(40) hour week over fifty-two&nbsp;(52) weeks for requested litigation and regulatory
cooperation that occurs after Executive&rsquo;s termination of employment, and reimburse Executive for all costs and expenses incurred
in connection with Executive&rsquo;s performance under this Section 18, including, but not limited to, reasonable attorneys&rsquo; fees
and costs, if the Company in its sole discretion deems that such compensation is reasonable and appropriate under the circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B><I>19. Section&nbsp;409A of the Code.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt; text-indent: 24.5pt">(a) Anything in this Agreement to
the contrary notwithstanding, if at the time of the Executive&rsquo;s separation from service within the meaning of Section&nbsp;409A
of the Code, the Company determines that the Executive is a &ldquo;specified employee&rdquo; within the meaning of Section&nbsp;409A(a)(2)(B)(i)
of the Code, then to the extent any payment or benefit that the Executive becomes entitled to under this Agreement on account of the Executive&rsquo;s
separation from service would be considered deferred compensation subject to the 20 percent additional tax imposed pursuant to Section&nbsp;409A(a)
of the Code as a result of the application of Section&nbsp;409A(a)(2)(B)(i) of the Code, such payment shall not be payable and such benefit
shall not be provided until the date that is the earlier of (A)&nbsp;six months and one day after the Executive&rsquo;s separation from
service, or (B)&nbsp;the Executive&rsquo;s death. Each payment of severance pay or other compensation under this Agreement is a separate
payment for purposes of section 409A of the Code. To the extent necessary to comply with Section 409A, if the time period for considering
and executing the Release under this Agreement spans two calendar years, then the severance or payment will not be made or commence until
the later calendar year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt; text-indent: 24.5pt">(b) The parties intend that this Agreement
will be administered in accordance with Section&nbsp;409A of the Code. To the extent that any provision of this Agreement is ambiguous
as to its compliance with Section&nbsp;409A of the Code, the provision shall be read in such a manner so that all payments hereunder comply
with Section&nbsp;409A of the Code. The parties agree that this Agreement may be amended, as reasonably requested by either party, and
as may be necessary to fully comply with Section&nbsp;409A of the Code and all related rules and regulations in order to preserve the
payments and benefits provided hereunder without additional cost to either party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt; text-indent: 24.5pt">(c) The determination of whether and
when a separation from service has occurred shall be made in accordance with the presumptions set forth in Treasury Regulation Section&nbsp;1.409A-1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt; text-indent: 24.5pt">(d) The Company makes no representation
or warranty and shall have no liability to the Executive or any other person if any provisions of this Agreement are determined to constitute
deferred compensation subject to Section&nbsp;409A of the Code but do not satisfy an exemption from, or the conditions of, such Section.
The parties agree to reasonably cooperate and work together to adopt amendments to this Agreement to the extent necessary to comply with
Section 409A of the Code with the intent to place Executive in the same or a substantially equivalent economic position.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt; text-indent: 24.5pt">(e)&nbsp;<B>Notwithstanding anything
herein to the contrary, if Section 409A of the Code is applicable, no event shall constitute a &ldquo;termination of employment&rdquo;
in this Agreement, unless such event is also a &ldquo;separation from service,&rdquo; as that term is defined for purposes of Section
409A of the Internal Revenue Code of 1986, as amended (&ldquo;Code&rdquo;), and Treasury Regulation &sect;1.409A-3(a)(1).</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B><I>20. Recoupment</I></B>. Notwithstanding
anything herein to the contrary, Executive may be required to forfeit or repay any or all compensation received by Executive under this
Agreement pursuant to the terms of any compensation recovery, recoupment or claw-back policy that may be adopted by or applicable to the
Company with respect to or under the Dodd-Frank Wall Street Reform and Consumer Protection Act or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;<B>21. Survival</B>.<B>&nbsp;</B>Notwithstanding
anything to the contrary in this Agreement, the provisions of Sections 4, 5, 6, 8 and 9 of this Agreement, and any other Sections of this
Agreement that must survive the termination of employment or expiration of the Agreement in order to effectuate the intent of the parties,
shall survive termination of Executive&rsquo;s employment or expiration of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>22. Review.</B>&nbsp;Executive acknowledges
that Executive was given a copy of this Agreement and at least ten (10) days to review the Agreement with legal counsel of Executive&rsquo;s
choosing, which Executive acknowledges is a reasonable and adequate time and opportunity to review. Executive acknowledges that the Company
indicated that Executive may review this Agreement, and specifically Section 5, with an attorney and has either exercised that right or
knowingly, willfully and freely decided not to do so. Executive further acknowledges that Executive has accepted the proposed Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>23. Binding Nature of Agreement.</B>&nbsp;This
Agreement shall be binding upon the Executive and upon Executive&rsquo;s heirs, administrators, representatives, executors, successors
and assigns, and shall inure to the benefit of the Executive and the Company and to their heirs, administrators, representatives, executors,
successors, and assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>24. Ownership of Inventions and Works of Authorship.</B>&nbsp;Executive
acknowledges that all ideas, developments, processes, discoveries, inventions, improvements, suggestions, derivations, modifications,
methods, programs, concepts, works, reports, procedures, data, documentation, writings, and applications, whether they are patentable
or not, which are made, devised, conceived, reduced to practice, developed or perfected by Executive alone or with any other person or
persons during the term of Executive&rsquo;s employment by the Company which relate to or arise out of the actual and/or anticipated business
activities of the Company and which were created using any Company resources of any kind, including other employees or by virtue of having
access to and/or using Confidential Information (&ldquo;Inventions&rdquo;) will be the sole and exclusive property of the Company. Executive
further acknowledges that all Inventions and original works of authorship which are made by Executive (solely or jointly with others)
within the scope of and during the period of Executive's employment with the Company and which are protectable by copyright are &ldquo;works
made for hire,&rdquo; as that term is defined in the United States Copyright Act (&ldquo;Works&rdquo;) and are solely and exclusively
owned by the Company. Executive agrees to disclose to the Company promptly and fully all Inventions and Works. For all Inventions, and
to the extent that any Works are not &ldquo;works made for hire,&rdquo; Executive hereby assigns and agrees to assign to the Company all
Executive&rsquo;s right, title and interest in and to all Inventions and such Works and all associated goodwill. Executive understands
and agrees that the decision whether or not to commercialize or market any Invention is within the Company&rsquo;s sole discretion and
for the Company&rsquo;s sole benefit, and that no royalty will be due to Executive as a result of the Company&rsquo;s efforts to commercialize
or market any such invention. Executive agrees to cooperate with and assist the Company, or its designee, in every proper way to secure
the Company&rsquo;s rights in the Inventions and any copyrights, patents, mask work rights or other intellectual property rights relating
thereto in any and all countries which the Company shall deem necessary in order to apply for and obtain such rights and in order to assign
and convey to the Company, its successors, assigns, and nominees the sole and exclusive rights, title and interest in and to such Inventions
and related goodwill, and any copyrights, patents, mask work rights or other intellectual property rights relating thereto. Executive
agrees that Executive&rsquo;s obligation to execute or cause to be executed, when it is in Executive&rsquo;s power to do so, any such
instrument or papers shall continue after the termination of this Agreement. If the Company is unable because of Executive&rsquo;s mental
or physical incapacity or for any other reason to secure Executive&rsquo;s signature to apply for or to pursue any application for any
United States or foreign patents or copyright registrations covering Inventions or original works of authorship assigned to the Company
as above, then Executive hereby irrevocably designates and appoints the Company&rsquo;s duly authorized officers as Executive&rsquo;s
agent and attorney in fact, to act for and on Executive&rsquo;s behalf and stead to execute and file any such applications and to do all
other lawfully permitted acts to further the prosecution and issuance of letters patent or copyright registrations thereon with the same
legal force and effect as if executed by Executive. Notwithstanding the foregoing, any provision in this Agreement requiring Executive
to assign or license, or to offer to assign or license, Executive&rsquo;s rights in any Development to the Company does not apply to an
invention or work of authorship that Executive developed entirely on Executive&rsquo;s own time without using or referring to the Company&rsquo;s
resources, equipment, supplies, facilities, or Confidential Information, except for those inventions or works of authorship that either:
(a) at the time of creation, conception or reduction to practice of the work or invention relate to the Company&rsquo;s business, or to
actual or demonstrably anticipated research or development of the Company, or (b) result from any work performed by Executive for the
Company; in which cases such provisions do apply. Executive acknowledges that Executive bears the burden of proving that an invention
or work of authorship is so exempt from the assignment provisions of this Agreement. Executive agrees to promptly disclose to the Company,
in confidence, all inventions or works of authorship made solely by Executive or jointly with others at any time during the term of Executive&rsquo;s
employment with the Company, for a review process under which the Company may determine such issues as may arise, including the Company&rsquo;s
rights and Executive&rsquo;s rights in such inventions or works of authorship.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>25. Third-Party Agreements and Rights</B>.
The Executive hereby confirms, that the Executive is not bound by the terms of any agreement with any previous employer or other party
which restricts in any way the Executive's use or disclosure of information or the Executive's engagement in any business. The Executive
represents to the Company that the Executive's execution of this Agreement, the Executive's employment with the Company and the performance
of the Executive's proposed duties for the Company will not violate any obligations the Executive may have to any such previous employer
or other party. In the Executive's work for the; Company, the Executive will not disclose or make use of any information in violation
of any agreements with or rights of any such previous employer or other party, and the Executive will not bring to the premises of the
Company any copies or other tangible embodiments of non-public information belonging to or obtained from any such previous employment
or third party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>26. Return of Company Property</B>. Upon termination
of Executive&rsquo;s employment with the Company or upon earlier demand by the Company, Executive agrees to immediately return all Company
property, including, but not limited to, any computer equipment, mobile phones, smartphones, iPhones, iPads and similar electronic devices,
office keys, credit and telephone cards, ID and access cards, and all original and duplicate copies of your work product and of files,
calendars, books, records, notes, notebooks, manuals, computer disks, diskettes, external drives, thumb drives, memory cards and sticks,
and any other digital, magnetic and other media materials Executive has in Executive's possession or control belonging to the Company,
or containing Confidential Information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[signatures on following page]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><I>IN WITNESS WHEREOF</I>, the parties have executed
this Agreement effective on the date and year first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">By the Company: &nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">/s/ James Green</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">James Green</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">President and CEO</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Date: June 19, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">By the Executive:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">/s/ Jennifer Cote</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Jennifer Cote</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: June 19, 2023&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp; &nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">EXHIBIT A- FORM OF GENERAL RELEASE OF CLAIMS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This Release Agreement (the &ldquo;<U>Release Agreement</U>&rdquo;)
is entered into by _______________________ (the &ldquo;<U>Executive</U>&rdquo;) in favor of Harvard Bioscience, Inc. (the &ldquo;<U>Company</U>&rdquo;).
This is the Release Agreement referenced in the Employment Agreement between the Executive and the Company dated __________________________
(the &ldquo;<U>Employment Agreement</U>&rdquo;). The consideration for the Executive&rsquo;s agreement to this Release Agreement consists
of certain termination benefits as set forth in the Employment Agreement and the terms of this Release Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Executive agrees as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><U>Release</U>. The Executive voluntarily releases
and forever discharges the Company and each of its subsidiaries, affiliates, predecessors, successors, assigns, and current and former
directors, officers, employees, representatives, attorneys, and agents (any and all of whom or which are hereinafter referred to as &ldquo;<U>Company
Parties</U>&rdquo;), from any and all charges, complaints, claims, liabilities, obligations, promises, agreements, controversies, damages,
actions, causes of action, suits, rights, demands, costs, losses, debts and expenses (including attorney&rsquo;s fees and costs actually
incurred), of any nature whatsoever, known or unknown (collectively, &ldquo;<U>Claims</U>&rdquo;) that the Executive now has, owns or
holds, or claims to have, own, or hold, or that Executive at any time had, owned, or held, or claimed to have had, owned, or held against
any Company Party or Parties. This general release of Claims includes, without implication of limitation, the release of all Claims:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 37px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&bull;</FONT></TD>
    <TD STYLE="width: 12px">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">relating to the Executive&rsquo;s employment by and termination from employment with the Company;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 37px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&bull;</FONT></TD>
    <TD STYLE="width: 12px">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">of wrongful discharge;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 37px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&bull;</FONT></TD>
    <TD STYLE="width: 12px">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">of breach of contract, including any claims under Executive&rsquo;s employment agreement;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 37px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&bull;</FONT></TD>
    <TD STYLE="width: 12px">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">of retaliation or discrimination under federal, state or local law (including, without limitation, Claims of age discrimination or retaliation under the Age Discrimination in Employment Act, Claims of disability discrimination or retaliation under the Americans with Disabilities Act, Claims of discrimination or retaliation under Title VII of the Civil Rights Act of 1964 and Claims of discrimination or retaliation under Mass. Gen. Laws ch. 151B);</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&bull;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">under the Massachusetts Equal Right Act, Massachusetts General Laws c.149 and 151B, and the federal and Massachusetts Fair Labor Standards Act,</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 37px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&bull;</FONT></TD>
    <TD STYLE="width: 12px">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">under any other federal or state statute, to the fullest extent that Claims may be released;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 37px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&bull;</FONT></TD>
    <TD STYLE="width: 12px">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">of defamation or other torts;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 37px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&bull;</FONT></TD>
    <TD STYLE="width: 12px">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">of violation of public policy;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 37px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&bull;</FONT></TD>
    <TD STYLE="width: 12px">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">for salary, bonuses, vacation pay or any other compensation or benefits; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 37px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&bull;</FONT></TD>
    <TD STYLE="width: 12px">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">for damages or other remedies of any sort, including, without limitation, compensatory damages, punitive damages, injunctive relief and attorney&rsquo;s fees.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">1.&nbsp;<U>Limitations on Release</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">(a)&nbsp;<U>Employment Agreement</U>. Nothing
in this Release Agreement limits the Executive&rsquo;s or the Company&rsquo;s rights under the Employment Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">(b)&nbsp;<U>Benefit and Enforcement Rights</U>.
Nothing in this Release Agreement is intended to release or waive the Executive&rsquo;s right to COBRA, unemployment insurance benefits
or any accrued and vested retirement benefits, the right to seek enforcement of this Release Agreement or any rights referenced in this
Section of this Release Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">(c)&nbsp;<U>Indemnification</U>. It is further
understood and agreed that the Executive&rsquo;s rights to indemnification as provided in the Company&rsquo;s certificate of incorporation,
bylaws, each as amended, or any indemnification agreement between the Company and the Executive (it being acknowledged and agreed by the
Executive that, as of the date of this Agreement, there are no amounts owing to the Executive pursuant to any such indemnification rights),
remain fully binding and in full effect subsequent to the execution of this Release Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">(d)&nbsp;<U>Exceptions</U>. This Release Agreement
does not prohibit or restrict the Executive from communicating, providing relevant information to or otherwise cooperating with the EEOC
or any other governmental authority with responsibility for the administration of fair employment practices laws regarding a possible
violation of such laws or responding to any inquiry from such authority, including an inquiry about the existence of this Release Agreement
or its underlying facts; provided that such interaction with EEOC or any other governmental authority shall not result in the Executive&rsquo;s
receipt of any monetary benefit or substantial equivalent thereof. This Release Agreement also does not preclude the Executive from benefiting
from classwide injunctive relief awarded in any fair employment practices case brought by any governmental agency; provided that such
relief does not result in the Executive&rsquo;s receipt of any monetary benefit or substantial equivalent thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">2.&nbsp;<U>No Assignment</U>. The Executive represents
that Executive has not assigned to any other person or entity any Claims against any Company Party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">3.&nbsp;<U>No Disparagement</U>. The Executive
shall not make any disparaging statements about the Company, members of the Board of Directors, any officer of the Company or any other
employee of the Company, and the Company&rsquo;s officers and directors shall be directed not to make any disparaging statements about
Executive. The Executive shall direct Executive&rsquo;s immediate family not to make any disparaging statements about any of the foregoing.
Any statement by a member of Executive&rsquo;s immediate family shall be deemed to be a statement by the Executive for purposes of this
paragraph. The Executive shall be considered to represent that Executive has complied and shall continue to comply with the non-disparagement
obligations under this paragraph from the Date of Termination (as defined in the Employment Agreement);&nbsp;<I>provided&nbsp;</I>that
this representation shall have no effect if this Release Agreement does not become effective. Notwithstanding the foregoing, nothing in
this paragraph shall be construed to apply to any statements made in the course of testimony in a legal proceeding or in any required
written statements in any such proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">4.&nbsp;<U>Litigation and Regulatory Cooperation</U>.
The Executive shall reasonably cooperate with the Company in the defense or prosecution of any claims or actions now in existence or which
may be brought in the future against or on behalf of the Company which relate to events or occurrences that transpired while Executive
was employed by the Company; provided, however, that such cooperation shall not materially and adversely affect Executive or expose Executive
to an increased probability of civil or criminal litigation. Executive&rsquo;s cooperation in connection with such claims or actions shall
include, but not be limited to, being available to meet with counsel to prepare for discovery or trial and to act as a witness on behalf
of the Company at mutually convenient times. Executive also shall cooperate fully with the Company in connection with any investigation
or review of any federal, state or local regulatory authority as any such investigation or review relates to events or occurrences that
transpired while Executive was employed by the Company. The Company shall also provide Executive with compensation on an hourly basis
at a rate equivalent to the hourly rate of the Executive&rsquo;s last annual Base Salary (as defined in the Employment Agreement) calculated
using a forty (40)&nbsp;hour week over fifty-two (52)&nbsp;weeks for requested litigation and regulatory cooperation that occurs after
Executive&rsquo;s termination of employment, and reimburse Executive for all costs and expenses incurred in connection with Executive&rsquo;s
performance under this Section&nbsp;5, including, but not limited to, reasonable attorneys&rsquo; fees and costs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">5.&nbsp;<U>Reaffirmation of Post-Employment Restrictive
Covenants</U>. The Executive reaffirms the restrictive covenants under the Employment Agreement to which Executive is subject, including
without limitation, the covenants restricting the disclosure and use of confidential information set forth in Section 4 of the Employment
Agreement and covenants regarding non-competition, non-solicitation and non-hiring set forth in Section 5 of the Employment Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">6.&nbsp;<U>Right to Consider and Revoke Release
Agreement</U>. This Release Agreement shall be considered to have been offered to the Executive on the Termination Date as defined in
the Employment Agreement. The Executive acknowledges that Executive has been given the opportunity to consider this Release Agreement
for a period ending twenty-one (21)&nbsp;days after the Termination Date. In the event that the Executive has executed this Release Agreement
within less than twenty-one (21)&nbsp;days of the Termination Date, the Executive acknowledges that such decision was entirely voluntary
and that Executive had the opportunity to consider this Release Agreement until the end of the twenty-one (21)&nbsp;day period. To accept
this Release Agreement, the Executive shall deliver a signed Release Agreement to the Company&rsquo;s Board of Directors within such twenty-one
(21)&nbsp;day period. The Executive acknowledges that for a period of seven&nbsp;(7) days from the date when the Executive executes this
Release Agreement (the &ldquo;<U>Revocation&nbsp;Period</U>&rdquo;), Executive shall retain the right to revoke this Release Agreement
by written notice that is received by the Board of Directors of the Company before the end of the Revocation Period. This Release Agreement
shall take effect only if it is executed by the Executive within the twenty-one (21)&nbsp;day period as set forth above and if it is not
revoked pursuant to the preceding sentence. If those conditions are satisfied, this Release Agreement shall become effective and enforceable
on the date immediately following the last day of the Revocation Period (the &ldquo;<U>Effective Date</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;7.&nbsp;<U>Consideration Owed</U>. Executive affirms and agrees
that as of the date of this Release Agreement, you acknowledge that you will be or have been paid any and all wages (including all base
compensation and, if applicable, any and all overtime, commissions, and bonuses) to which you are or were entitled as of the date of termination
of employment, and that no other wages (including all base compensation and, if applicable, any and all incentive compensation and bonuses)
are due to Executive. Executive acknowledges that Executive is unaware of any facts or circumstances indicating that Executive may have
an outstanding claim for unpaid wages, improper deductions from pay, or any violation of the Fair Labor Standards Act or any other federal,
state or local laws, rules, ordinances or regulations that are related to payment of wages.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">8.&nbsp;<U>Other Terms</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">(a)&nbsp;<U>Legal Representation; Review of Release
Agreement</U>. The Executive acknowledges that Executive has been advised to discuss all aspects of this Release Agreement with Executive&rsquo;s
attorney. The Executive represents that Executive has carefully read and fully understands all of the provisions of this Release Agreement
and that Executive is voluntarily entering into this Release Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">(b)&nbsp;<U>Binding Nature of Release Agreement</U>.
This Release Agreement shall be binding upon the Executive and upon Executive&rsquo;s heirs, administrators, representatives, executors,
successors and assigns, and shall inure to the benefit of the Executive and the Company and to their heirs, administrators, representatives,
executors, successors, and assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">(c)&nbsp;<U>Modification of Release Agreement;
Waiver</U>. This Release Agreement may be amended, revoked, changed, or modified only upon a written agreement executed by both the Executive
and the Company. No modification waiver of any provision of this Release Agreement will be valid unless it is in writing and signed by
the party against whom such waiver is charged. The failure of the Company to require the performance of any term or obligation of this
Release Agreement, or the waiver by the Company of any breach of this Release Agreement, shall not prevent any subsequent enforcement
of such term or obligation or be deemed a waiver of any subsequent breach.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">(d)&nbsp;<U>Severability</U>. In the event that
at any future time it is determined by a court of competent jurisdiction that any covenant, clause, provision or term of this Release
Agreement is illegal, invalid or unenforceable, the remaining provisions and terms of this Release Agreement shall not be affected thereby
and the illegal, invalid or unenforceable term or provision shall be severed from the remainder of this Release Agreement. In the event
of such severance, the remaining covenants shall be binding and enforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">(e)&nbsp;<U>Enforcement</U>. Sections 4, 5 and
6 of this Release Agreement shall be subject to enforcement pursuant to the same procedures that apply to a breach of Sections 4 or 5
of the Employment Agreement (as further detailed in Section 16 of the Employment Agreement). Any other disputes concerning this Release
Agreement shall be subject to resolution pursuant to Section&nbsp;16 of the Employment Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">(f)&nbsp;<U>Governing Law and Interpretation</U>.
This Release Agreement shall be deemed to be made and entered into in the state of Massachusetts, and shall in all respects be interpreted,
enforced and governed under the laws of Massachusetts, without giving effect to conflict of laws provision. The language of all parts
of this Release Agreement shall in all cases be construed as a whole, according to its fair meaning, and not strictly for or against the
Executive or the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">(h)&nbsp;<U>Entire Agreement; Absence of Reliance</U>.
This Release Agreement constitutes the entire agreement of the Executive concerning any subject matter of this Release Agreement and supersedes
all prior agreements between the Executive and the Company with respect to any related subject matter, except the Employment Agreement.
The Executive acknowledges that Executive is not relying on any promises or representations by the Company or its agents, representatives
or attorneys regarding any subject matter addressed in this Release Agreement, other than the provision of the Employment Agreement pursuant
to which Executive is to receive certain consideration in return for signing this Release Agreement and allowing it to become effective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">So agreed by the Executive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 30%">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>exh_991.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><html lang="en-US"><head><title>EdgarFiling</title><meta content="text/html; charset=windows-1252" /><meta name="GENERATOR" content="MSHTML 8.00.7601.18094" /></head><body bgcolor="#ffffff"><p style="text-align: right;"><strong>EXHIBIT 99.1</strong></p><p style="text-align: center;"><font style="font-size: 14pt;"><strong>Harvard Bioscience Appoints Jennifer Cote as Chief Financial Officer</strong></font></p><p style="text-align: center;"><strong>Has served in interim role since January 2023</strong></p><p>
   <p>HOLLISTON, Mass., June  20, 2023  (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the &#8220;Company&#8221;) today announced the appointment of Jennifer Cote as the Company&#8217;s Chief Financial Officer and Treasurer, effective June 19, 2023. Cote joined the Company as Vice President of Global Finance in May 2022 and has served as Interim Chief Financial Officer and Treasurer since January 2023.<br /></p>    <p>Jim Green, Chairman and CEO said, &#8220;Originally joining us as our Vice President of Global Finance, Jennifer brought extensive experience in areas including global financial and operational leadership, corporate strategy, accounting and internal controls, and strong fiscal management. Since assuming the role of Interim CFO earlier this year, she has already demonstrated strong leadership, financial acumen, and a deep understanding of our business. We look forward to Jennifer&#8217;s ongoing contributions as we focus on our priorities of driving sustainable, profitable growth, improved operating discipline, and reducing our debt. On behalf of our board of directors and our senior leadership team, I would like to welcome Jennifer to her new role.&#8221;</p>    <p>Prior to joining Harvard Bioscience, Cote held various financial, strategy, and operating roles of increasing responsibility at Bose Corporation, a leading supplier of speakers, headphones, electronics and other related products for the consumer audio, automotive, health, and professional audio market. During her tenure at Bose, she led various teams as Head of Strategy Enablement and Finance Services for Bose&#8217;s Global Business Services organization, Head of Finance for Bose&#8217;s Headphones Business Unit, and Head of Global Business Operations and Head of Finance for Bose&#8217;s Professional Systems Division. Earlier in her career, Ms. Cote held various positions of increasing responsibility, including Audit Manager, at Arthur Andersen LLP. A Certified Public Accountant and Chartered Global Management Accountant, Cote holds a Bachelor of Science in Accountancy from Villanova University.</p>    <p><strong>About Harvard Bioscience</strong><br />Harvard Bioscience, Inc. is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. Our customers range from renowned academic institutions and government laboratories to the world&#8217;s leading pharmaceutical, biotechnology and contract research organizations. With operations in North America, Europe, and China, we sell through a combination of direct and distribution channels to customers around the world.&#160;For more information, please visit our website at&#160;<u>www.harvardbioscience.com</u>.</p>    <p><strong>Forward-Looking Statements</strong><br />This document contains forward-looking statements within the meaning of the federal securities laws, including the Private Securities Litigation Reform Act of 1995. Forward looking statements may be identified by the use of words such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;estimate,&#8221; &#8220;intend&#8221; and similar expressions or statements that do not relate to historical matters. Forward-looking statements include, but are not limited to, information concerning expected future revenues, earnings, cash position, growth, operational performance, and the strength of the Company&#8217;s market position and business model. Forward-looking statements are not guarantees of future performance and involve known and unknown uncertainties, risks, assumptions, and contingencies, many of which are outside the Company's control. Risks and other factors that could cause the Company&#8217;s actual results to differ materially from those described its forward-looking statements include those described in the &#8220;Risk Factors&#8221; section of the Company&#8217;s most recently filed Annual Report on Form 10-K as well as in the Company&#8217;s other filings with the Securities and Exchange Commission. Forward-looking statements are based on the Company&#8217;s expectations and assumptions as of the date of this document. Except as required by law, the Company assumes no obligation to update forward-looking statements to reflect any change in expectations, even as new information becomes available.</p>    <p><strong>Investor Inquiries:</strong><br />Harvard Bioscience, Inc.<br />Investor Relations<br /><u>investors@harvardbioscience.com</u><br />(508) 893-3120</p> </p><p /></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>hbio-20230619.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: /qlZs7xRiXgen8uAbXMsOamHCaOdx5B7yekxt211HZn6byEj9Id5Xi0F/zLGwe4G -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:HBIO="http://harvardbioscience.com/20230619" elementFormDefault="qualified" targetNamespace="http://harvardbioscience.com/20230619">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://harvardbioscience.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="hbio-20230619_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="hbio-20230619_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>hbio-20230619_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>hbio-20230619_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://harvardbioscience.com/role/Cover" xlink:href="hbio-20230619.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://harvardbioscience.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139791188729344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jun. 19, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 19,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33957<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">HARVARD BIOSCIENCE, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001123494<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-3306140<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">84 October Hill Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Holliston<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">01746<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(508)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">893-8999<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HBIO<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>f8k_062023_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="hbio-20230619.xsd" xlink:type="simple"/>
    <context id="From2023-06-19to2023-06-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001123494</identifier>
        </entity>
        <period>
            <startDate>2023-06-19</startDate>
            <endDate>2023-06-19</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2023-06-19to2023-06-19">0001123494</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2023-06-19to2023-06-19">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2023-06-19to2023-06-19">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2023-06-19to2023-06-19">2023-06-19</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2023-06-19to2023-06-19">HARVARD BIOSCIENCE, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2023-06-19to2023-06-19">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2023-06-19to2023-06-19">001-33957</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2023-06-19to2023-06-19">04-3306140</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2023-06-19to2023-06-19">84 October Hill Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2023-06-19to2023-06-19">Holliston</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2023-06-19to2023-06-19">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2023-06-19to2023-06-19">01746</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2023-06-19to2023-06-19">(508)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2023-06-19to2023-06-19">893-8999</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2023-06-19to2023-06-19">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2023-06-19to2023-06-19">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2023-06-19to2023-06-19">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2023-06-19to2023-06-19">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2023-06-19to2023-06-19">Common Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-06-19to2023-06-19">HBIO</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-06-19to2023-06-19">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2023-06-19to2023-06-19">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M%#X >P-<7REEW@=VNUK^MV'P+U!+ P04    " #E0=16GZ ;\+$"  #B#
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M#ZP+V.Q _G@>F*FX3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X
M%F>0IA@"IQ%', ;  4/2='@//GL?)=-[*CG_5U/\!%!+ P04    " #E0=16
MEXJ[',     3 @  "P   %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S
M9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X
M 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D5XA<UYVE/=LO
M3T%O@*\Z3'%":4A+,P[PS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A(E@6FD7)
MTZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0
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MBBJ6<%H@XLD@;6E6?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @
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MX3]>?P%02P$"% ,4    " #E0=16!T%-8H$   "Q    $
M@ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( .5!U%;@S T([@
M "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4
M Q0    ( .5!U%:97)PC$ 8  )PG   3              "  <P!  !X;"]T
M:&5M92]T:&5M93$N>&UL4$L! A0#%     @ Y4'45E.T^!=+!   >1   !@
M             ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4
M Q0    ( .5!U%:?H!OPL0(  .(,   -              "  8X,  !X;"]S
M='EL97,N>&UL4$L! A0#%     @ Y4'45I>*NQS     $P(   L
M     ( !:@\  %]R96QS+RYR96QS4$L! A0#%     @ Y4'45JK$(A8S 0
M(@(   \              ( !4Q   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0
M   ( .5!U%8D'INBK0   /@!   :              "  ;,1  !X;"]?<F5L
M<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( .5!U%9ED'F2&0$  ,\#
M   3              "  9@2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@
0   )  D /@(  .(3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="f8k_062023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://harvardbioscience.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="f8k_062023.htm">f8k_062023.htm</File>
    <File>exh_101.htm</File>
    <File>exh_991.htm</File>
    <File>hbio-20230619.xsd</File>
    <File>hbio-20230619_lab.xml</File>
    <File>hbio-20230619_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "f8k_062023.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "f8k_062023.htm"
     ]
    },
    "labelLink": {
     "local": [
      "hbio-20230619_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "hbio-20230619_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "hbio-20230619.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2023": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "HBIO",
   "nsuri": "http://harvardbioscience.com/20230619",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "f8k_062023.htm",
      "contextRef": "From2023-06-19to2023-06-19",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://harvardbioscience.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "f8k_062023.htm",
      "contextRef": "From2023-06-19to2023-06-19",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://harvardbioscience.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001171843-23-003988-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001171843-23-003988-xbrl.zip
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M+3O8A:Z8PC]6=!-I7D P,V"/^/(LSPND"Z VG@<=95&=TNBX!A$.]"+X2Y4
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M@48],0)8-"L^(\2S*#-0%&0/UYZCU1GE\ ?.%4W!HH-- 0.R(&/5SIB5.Q#
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M9K=$[Q:$(#5.%7N0;-G8BRL<4-P[ %.E@J ![D]L.D):4H]M;@Q+B5CN#"
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ME35'^Y%2Z >T",I-%GE59J"%8#:I+>NVO=0;AH0CAVWN7XS/C.ZS:KFH-SR
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M=UE):E R(65&-Z?A7E_>W FC*[83T99)3L2N*;@YH=OIYEQ30_8E^BZ&RK6
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M^L(N:04Q)<^2;SIHK7Y*H7-&G\P5O]3<?7-#RH'K6<JY>HB"Z=S_[)(#FA/
MM%J%P@>V4*+3?.\DH.D%#(N3V-S+9&:<%"Y14<EJD7_I8VO\;%I;>4F\ 1F/
M9)[2[1-V9?-*"]=[YTV,C.(RH]B,Q?3TAK,%'1-,+?LB5LI H;Y5KSZ'QOK[
MT8REKL5I+TA+<Y8(P!RA,1JI65:HD!R0B4[+8[=0>J)''O',M==16/4B.\^
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M,6E4G2'!H[2FYQYD6;"0DD$IWLDJ1AHQ\PG8 :[W2B#VBHJV0M2#LH:?B%Z
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M,Q-!PC.[1V3R:#=YZS#K84./,<G$HT3]!J8_"<L#RM/ IX8X+IQ;[^+1L>7
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M]=MTQE-*P?$%._00#[LD"QPH&!,B;.O@,5O( =>QWL,]&?7E'KK3M%QV _Z
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M3VVR,T?M:"R"=RUK*5HSDQB7=LOGZ-@==;QE9B0#5?!LIXSGC E.C RUG=I
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MR 6EB6K@#OP5:5^!%9U1>^&9[<(&ES0-QJDI W=N*&ET7A!(NZ"I2&KSMC<
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MV>V=Q9][R9^%3XU'O$6(JK_<@%]F[^RO T9-#-VCZ^R5]\O2[%C=O&^@ -.
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MWQTCE.L55"Z7\*UF6*#T32$R'QIF: 2R+&.I>9DM-(;$N>(2ZXHH+FIYYQ?
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MW_.8B O%',2):%M\*^I'^D^WN7P,Z8'M]F8V[D4\\H;L9V&JS02S>Q=2W+>
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M@_W@9/MK%__(P3_T\:]^OBI/_@102P,$%     @ Y4'45D_4,(!(&   S'(
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M\C[8O7]DL^20,T/?(5WF[I)S.F([9*R/=TG[0/YP4R@U;ZZ['TH'G^KU2_A
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M=X2,I$  D>%Q9ZB\*1A>-C"7W%CH&?^Q"Y[B8T;PD6TPY1U\5''@"IVP/"?
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MR6D^0G\6N7@TF3PLE +O@&E3<)L ;G4ECB%T&!%7H%R3+^Y H.K8%K B6'J
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M40JDXO6YT )>@QY49M&CC P^X+CU!\L*J4%2B N*#1%'H[!H#-RF3!6UH 9
M]8YIHIRUNM*P3$]$Z ,J^L!Y\)B:5-YJX8/\&CD<61'X(4-80-+R5K"Z8ECF
M("M5-%P OI$+Z,%K9^"B/!ME!2.4)P?352HJ"!/8P@2)HT0FB=E/P\*L/UI$
M$6DI\K8/J)7L6#C,ZD,E,!>ZV)@+F:GX[.XAWP*RT&*DY2)1TY%QTGT-&F'1
M!?^J;%ZFO(YT_TJ7N1/.E^M463C$&JG25,X*EQBJ\[MM.*E&TU0/<%'XKA:8
MCBH5\9C(Q(%EZ01#)5:[#O::XH/ U8H0Q*RDI1):'AH!]I_6,!_V?*\G) \C
M+=\8^]8W9N" K&S(K2.NG] 1!D&4*NHJBNN1&:"A:\72.I&7OT6"H1#,T3"8
MZ_[%]H!ZF;VZ:$* B8->/F#<"9IC,!!=\%IQ75K3AJP[K2P @Q\LQV\'8!J*
M^8'42&G)T^15>>P8NB@VTR*8]3K**ZM$L#AM?X?GEGWDJ(+*M1C>"!3"&RD^
M^%J[NB)WXH+E-R\:G3HF>R/NC11)LPN3Y(5H$&D"@W+DVO:=<R+[,#IXY@/8
M/LA4F1L&X\!W^):GH@BLW 7-<GV/K0=>7RF'OW!Y;$4U)(7<2Y$@PF N9G.
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M/;K!&W*&?B*4<)PS_CWZAM.MW,*NDI1P-&.;YY3D1!24.SY#WQU-_[Y"X_&
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MZ;'=?F@&$ >!TQ"'P*,S,FC\)*.0"JNNA'DAZ1M+MS3'O'B7G-M&)D#GEAS
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MT'5G#[@WUA;?N%_NK:SVR/]02P$"% ,4    " #E0=1644$;/>9@  #)VP$
M"P              @ $     97AH7S$P,2YH=&U02P$"% ,4    " #E0=16
MU$UV634)  #:%   "P              @ $/80  97AH7SDY,2YH=&U02P$"
M% ,4    " #E0=163]0P@$@8  #,<@  #@              @ %M:@  9CAK
M7S V,C R,RYH=&U02P$"% ,4    " #E0=16<U%4"3 #  #&"P  $0
M        @ 'A@@  :&)I;RTR,#(S,#8Q.2YX<V102P$"% ,4    " #E0=16
MH4WVW?X*  " A@  %0              @ % A@  :&)I;RTR,#(S,#8Q.5]L
M86(N>&UL4$L! A0#%     @ Y4'45O%].[);!P  YU<  !4
M ( !<9$  &AB:6\M,C R,S V,3E?<')E+GAM;%!+!08     !@ & ',!  #_
%F      !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
